As of 2025-07-04, the Intrinsic Value of Biovaxys Technology Corp (BIOV.CN) is -0.09 CAD. This BIOV.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.04 CAD, the upside of Biovaxys Technology Corp is -369.86%.
Based on its market price of 0.04 CAD and our intrinsic valuation, Biovaxys Technology Corp (BIOV.CN) is overvalued by 369.86%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
Range | Selected | Upside | |
a | |||
Fair Value | -0.09 - -0.09 | -0.09 | -369.86% |
P/E | (0.00) - (0.00) | (0.00) | -102.7% |
DDM - Stable | (0.41) - 4.89 | 2.24 | 6300.1% |
DDM - Multi | (0.29) - 2.68 | (0.65) | -1943.1% |
Market Cap (mil) | 10.27 |
Beta | 0.07 |
Outstanding shares (mil) | 293.43 |
Enterprise Value (mil) | 10.18 |
Market risk premium | 5.10% |
Cost of Equity | 5.45% |
Cost of Debt | 5.00% |
WACC | 5.44% |